Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | GFER | P55789 | 1/20 | 0.62 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17055827 | 0.81 | KMT2A (0.53) | ALOX15GFERADAM17ALDH1A1POLB | |
| SCHEMBL24665314 | 0.81 | ALOX15 (0.43) | ALOX15GFERADAM17KDM4ELMNA | |
| SCHEMBL17064043 | 0.79 | RAB9A (0.50) | ALOX15GFERADAM17ATMPOLB | |
| SCHEMBL21740372 | 0.76 | ALOX15 (0.52) | ALOX15GFERADAM17ATMALDH1A1 | |
| SCHEMBL12348299 | 0.76 | HSD17B10 (0.36) | ALOX15ALDH1A1LMNA | |
| SCHEMBL23578113 | 0.75 | ACACB (0.40) | ALOX15GFERADAM17MAPTHTT | |
| SCHEMBL23578547 | 0.75 | ACACB (0.40) | ALOX15GFERADAM17MAPTHTT | |
| SCHEMBL23578115 | 0.75 | ACACB (0.40) | ALOX15GFERADAM17MAPTHTT | |
| Hydrochloric Acid SCHEMBL9060564 | 0.74 | ST14 (0.57) | ALOX15GFERADAM17 | |
| SCHEMBL8716162 | 0.74 | TAS1R3 (0.38) | ALOX15GFERADAM17KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6841661-B2 | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | PRINCETON UNIVERISITY (US) | 2005-01-11 | — | — | US | claimed |
| US-20030224975-A1 | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | PRINCETON UNIVERSITY (US) | 2003-12-04 | — | — | US | claimed |
| US-6498238-B1 | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | PRINCETON UNIVERSITY | 2002-12-24 | — | — | US | claimed |
| EP-4463452-B1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC (US) | 2025-07-30 | — | — | EP | disclosed |
| US-12344600-B2 | c-Myc mRNA translation modulators and uses thereof in the treatment of cancer | ANIMA BIOTECH INC. (US) | 2025-07-01 | — | — | US | disclosed |
| US-20250109128-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2025-04-03 | — | — | US | disclosed |
| EP-4463452-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | Anima Biotech Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| WO-2023177700-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| EP-3275440-B1 | NOVEL OXADIAZOLE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME | NAT CT GERIATRICS & GERONTOLOGY (JP) | 2022-05-04 | — | — | EP | disclosed |
| US-20180072708-A1 | NOVEL OXADIAZOLE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME | NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) | 2018-03-15 | — | — | US | disclosed |
| US-20180072708-A1 | NOVEL OXADIAZOLE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME | NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) | 2018-03-15 | — | — | US | disclosed |
| WO-2014031928-A2 | HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE | JONES PHILIP (US) | 2014-02-27 | — | — | WO | disclosed |
| EP-1423120-A4 | 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF | ICOS CORP (US) | 2005-12-28 | — | — | EP | disclosed |
| US-6924284-B2 | PARP inhibitors | ICOS CORPORATION (US) | 2005-08-02 | — | — | US | disclosed |
| US-6841661-B2 | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | PRINCETON UNIVERISITY (US) | 2005-01-11 | — | — | US | disclosed |
| EP-1423120-A1 | 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF | ICOS CORPORATION (US) | 2004-06-02 | — | — | EP | disclosed |
| US-20040087588-A1 | Parp inhibitors | ICOS CORPORATION | 2004-05-06 | — | — | US | disclosed |
| US-20030224975-A1 | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | PRINCETON UNIVERSITY (US) | 2003-12-04 | — | — | US | disclosed |
| WO-2003015785-A1 | 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF | ICOS CORPORATION (US) | 2003-02-27 | — | — | WO | disclosed |
| US-6498238-B1 | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | PRINCETON UNIVERSITY | 2002-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030224975-A1 | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | FUT6, GALNT6, UGCG | ALOX15 1880/4885GFER 413/4885ADAM17 1981/4885 |
| US-20040087588-A1 | Parp inhibitors | PARP1, PARP2, PARP11 | ALOX15 1940/4885GFER 3595/4885ADAM17 1357/4885 |
| US-12344600-B2 | c-Myc mRNA translation modulators and uses thereof in the treatment of cancer | MYC, MYCBP, MYCBP2 | ALOX15 3870/4885GFER 4267/4885ADAM17 4344/4885 |
| US-20250109128-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | MYC, MYCBP, MYCBP2 | ALOX15 3870/4885GFER 4267/4885ADAM17 4344/4885 |
| US-20180072708-A1 | NOVEL OXADIAZOLE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME | APP, BACE1, PSEN1 | ALOX15 1146/4885GFER 251/4885ADAM17 683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.